Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention

Background. Inflammation poses dual effects after myocardial infarction, but robust evidence shows that high-sensitivity C-reactive protein (hsCRP), as an inflammatory marker, is constantly associated with worse outcomes. This study is aimed at investigating the probable nonlinear association betwee...

Full description

Saved in:
Bibliographic Details
Main Authors: Runzhen Chen, Chen Liu, Peng Zhou, Yu Tan, Zhaoxue Sheng, Jiannan Li, Jinying Zhou, Yi Chen, Li Song, Hanjun Zhao, Hongbing Yan
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2020/9343475
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566151839744000
author Runzhen Chen
Chen Liu
Peng Zhou
Yu Tan
Zhaoxue Sheng
Jiannan Li
Jinying Zhou
Yi Chen
Li Song
Hanjun Zhao
Hongbing Yan
author_facet Runzhen Chen
Chen Liu
Peng Zhou
Yu Tan
Zhaoxue Sheng
Jiannan Li
Jinying Zhou
Yi Chen
Li Song
Hanjun Zhao
Hongbing Yan
author_sort Runzhen Chen
collection DOAJ
description Background. Inflammation poses dual effects after myocardial infarction, but robust evidence shows that high-sensitivity C-reactive protein (hsCRP), as an inflammatory marker, is constantly associated with worse outcomes. This study is aimed at investigating the probable nonlinear association between postprocedural hsCRP and mortality in patients with acute coronary syndromes (ACS) treated by percutaneous coronary intervention (PCI). Methods. A total of 3940 consecutive ACS patients treated by PCI with postprocedural hsCRP measurements were retrospectively recruited. Patients were stratified into 5 groups according to quintiles of hsCRP. Cox regression with adjustments for multiple covariates was used for outcome analysis. Restricted cubic spline (RCS) analysis was used to allow possible nonlinear associations. The primary outcome was all-cause death. Results. During a median follow-up of 727 days, mortality occurred in 207 (5.3%) patients. Adjusted hazard ratio (HR) was higher in the lowest (<2.26 mg/L, HR: 1.90, 95% confidence interval (CI): 1.08-3.33; P=0.025), second highest (10.16-12.56 mg/L, HR: 1.86, 95% CI: 1.09-3.16; P=0.023), and highest quintiles (≥12.56 mg/L, HR: 2.02, 95% CI: 1.21-3.36; P=0.007) of postprocedural hsCRP, compared to the second lowest quintile (2.26-4.85 mg/L). RCS analysis depicted a J-shaped association between postprocedural hsCRP and mortality (P for nonlinearity=0.004). Similar association was observed between hsCRP and cardiac death (P for nonlinearity=0.014), but not for noncardiac mortality (P for nonlinearity=0.228). Conclusions. Both low and high postprocedural hsCRP were associated with higher risk of death in ACS patients treated by PCI.
format Article
id doaj-art-a209338591144d6ead00abc80d28dee9
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-a209338591144d6ead00abc80d28dee92025-02-03T01:05:02ZengWileyMediators of Inflammation0962-93511466-18612020-01-01202010.1155/2020/93434759343475Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary InterventionRunzhen Chen0Chen Liu1Peng Zhou2Yu Tan3Zhaoxue Sheng4Jiannan Li5Jinying Zhou6Yi Chen7Li Song8Hanjun Zhao9Hongbing Yan10Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaBackground. Inflammation poses dual effects after myocardial infarction, but robust evidence shows that high-sensitivity C-reactive protein (hsCRP), as an inflammatory marker, is constantly associated with worse outcomes. This study is aimed at investigating the probable nonlinear association between postprocedural hsCRP and mortality in patients with acute coronary syndromes (ACS) treated by percutaneous coronary intervention (PCI). Methods. A total of 3940 consecutive ACS patients treated by PCI with postprocedural hsCRP measurements were retrospectively recruited. Patients were stratified into 5 groups according to quintiles of hsCRP. Cox regression with adjustments for multiple covariates was used for outcome analysis. Restricted cubic spline (RCS) analysis was used to allow possible nonlinear associations. The primary outcome was all-cause death. Results. During a median follow-up of 727 days, mortality occurred in 207 (5.3%) patients. Adjusted hazard ratio (HR) was higher in the lowest (<2.26 mg/L, HR: 1.90, 95% confidence interval (CI): 1.08-3.33; P=0.025), second highest (10.16-12.56 mg/L, HR: 1.86, 95% CI: 1.09-3.16; P=0.023), and highest quintiles (≥12.56 mg/L, HR: 2.02, 95% CI: 1.21-3.36; P=0.007) of postprocedural hsCRP, compared to the second lowest quintile (2.26-4.85 mg/L). RCS analysis depicted a J-shaped association between postprocedural hsCRP and mortality (P for nonlinearity=0.004). Similar association was observed between hsCRP and cardiac death (P for nonlinearity=0.014), but not for noncardiac mortality (P for nonlinearity=0.228). Conclusions. Both low and high postprocedural hsCRP were associated with higher risk of death in ACS patients treated by PCI.http://dx.doi.org/10.1155/2020/9343475
spellingShingle Runzhen Chen
Chen Liu
Peng Zhou
Yu Tan
Zhaoxue Sheng
Jiannan Li
Jinying Zhou
Yi Chen
Li Song
Hanjun Zhao
Hongbing Yan
Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
Mediators of Inflammation
title Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
title_full Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
title_fullStr Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
title_full_unstemmed Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
title_short Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention
title_sort both low and high postprocedural hscrp associate with increased risk of death in acute coronary syndrome patients treated by percutaneous coronary intervention
url http://dx.doi.org/10.1155/2020/9343475
work_keys_str_mv AT runzhenchen bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT chenliu bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT pengzhou bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT yutan bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT zhaoxuesheng bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT jiannanli bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT jinyingzhou bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT yichen bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT lisong bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT hanjunzhao bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention
AT hongbingyan bothlowandhighpostproceduralhscrpassociatewithincreasedriskofdeathinacutecoronarysyndromepatientstreatedbypercutaneouscoronaryintervention